HOOKIPA PHARMA INC. Asset Impairment Charges
HOOKIPA PHARMA INC. reported Asset Impairment Charges of $4.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-02-28
- HOOKIPA PHARMA INC. asset impairment charges for the quarter ending 2024-12-31 was $3.83M.
- HOOKIPA PHARMA INC. asset impairment charges for fiscal 2024 was $4.00M, a 68.64% decline from fiscal 2023.
- HOOKIPA PHARMA INC. asset impairment charges for fiscal 2023 was $12.77M.
- HOOKIPA PHARMA INC. asset impairment charges for fiscal 2022 was $0.00.
- HOOKIPA PHARMA INC. asset impairment charges for fiscal 2021 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|
| 2024-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.00M 10-K · filed 2025-02-28 | |
| 2024-09-30 | $172.00K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $12.77M 10-K · filed 2025-02-28 | ||
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-15 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-24 |